Rapeseed Lecithin.

Phosphatidylcholine is the main phospholipid in any lecithin fraction, so the properties credited to lecithin are largely its properties.

Phospholipases cleave the choline headgroup from phosphatidylcholine, so lecithin acts as a slow-release dietary source of choline.

Choline is oxidised to betaine, which then donates a methyl group to remethylate homocysteine. Lecithin feeds the front of that route and betaine sits at its output.

Lecithin is a natural emulsifier that disperses triglyceride droplets into finer particles for lipase to act on, which is why it is a standing excipient in oil-based formats.

CoQ10 is highly lipophilic and dissolves poorly on its own. Lecithin-based dispersions raise the surface area available for micelle formation, which is long-standing delivery practice.

Curcumin phytosome preparations are curcumin bound to phospholipid, which is the standard route for getting a compound of that solubility into circulation.

Cholecalciferol needs a lipid phase and bile micelles to be absorbed, and a lecithin carrier supplies the emulsified phase in dry or aqueous formats.

Phosphatidylserine is made in the body by exchanging the headgroup on phosphatidylethanolamine and phosphatidylcholine, so lecithin supplies the backbone that route works from.

Lecithin fractions carry phosphatidylinositol alongside phosphatidylcholine, and inositol is the headgroup of that phospholipid and the source of the signalling inositol phosphates.

Lecithin phospholipids carry unsaturated acyl chains that oxidise. Tocopherol sits in the same lipid layer and interrupts the radical chain.

Retinol and retinyl esters need bile salts and dietary phospholipid to form mixed micelles before they cross the enterocyte membrane. Lecithin phospholipids contribute directly to that micellar phase. This is standard absorption physiology for a fat-soluble vitamin rather than a claim specific to rapeseed lecithin.

Menaquinone-7 is strongly lipophilic and its uptake depends on a lipid phase in the meal. Phosphatidylcholine acts as an emulsifier that keeps it dispersed through digestion. Formulators use lecithin for exactly this reason in oil-free capsule and powder formats.

Astaxanthin is a xanthophyll carotenoid with very low water solubility, and its plasma appearance rises when it is taken with lipid. Lecithin provides both an emulsifier and a phospholipid carrier in dry formats where free oil is not wanted. The mechanism is micellar solubilisation, a marker-level effect on absorption rather than a health outcome.

Carotenoid absorption is limited by how much of the compound partitions into mixed micelles. Added phospholipid raises that partitioning. Studies of carotenoid bioavailability measure serum concentration, which is a marker of uptake and not a clinical endpoint.

Lycopene is among the least water-soluble carotenoids and its uptake is the most lipid-dependent of the group. Lecithin supports its dispersion into the micellar phase during digestion. What improves is measured absorption, not a demonstrated downstream effect.

Provitamin A carotenoids need a lipid vehicle to be taken up and then cleaved by BCO1 in the enterocyte. Phospholipid emulsifiers support the first of those steps. The relationship is a settled part of carotenoid absorption physiology.

Ubiquinol is a large lipophilic quinol with famously poor aqueous solubility, and commercial softgels routinely carry lecithin as a dispersant. The phospholipid keeps it from crystallising out of the oil phase. Serum coenzyme Q10 is the readout in these formulation studies, which is a marker of delivery.

Medium chain triglycerides supply the oil phase and lecithin supplies the emulsifier, which is the standard pairing for a self-emulsifying delivery system. Together they hold a lipophilic active in fine dispersion when it meets gastric fluid. Each does a different job in the same formulation.

Krill oil already carries its EPA and DHA in phospholipid form, so pairing it with lecithin adds more of the same structural class rather than a different one. Both supply phosphatidylcholine to the gut lumen. The pairing is additive on phospholipid intake and duplicative in intent.

Triglyceride and ethyl ester fish oils depend on lipase action and bile for uptake, and emulsification raises the surface area available to lipase. Lecithin is a common emulsifier in fish oil emulsions and powders for this reason. The measured effect sits at the absorption step.

Choline liberated from phosphatidylcholine is oxidised to betaine, which donates a methyl group to homocysteine through BHMT. Folate feeds the parallel methionine synthase route. The two pathways back each other up, which is textbook one-carbon metabolism.

Methionine synthase needs cobalamin as its cofactor to remethylate homocysteine using folate. When that route is limited, the choline-to-betaine route carries more of the load. Choline supply and B12 status therefore sit on either side of the same junction.

Pyridoxal 5-phosphate is the cofactor for cystathionine beta-synthase, the transsulfuration exit from homocysteine. Methyl donors from choline handle remethylation, the other branch. Covering both branches is standard homocysteine biochemistry.

S-adenosylmethionine is the methyl donor for the PEMT pathway that builds phosphatidylcholine from phosphatidylethanolamine, consuming three methyl groups per molecule. Dietary phosphatidylcholine from lecithin reduces the demand placed on that route. The two intersect directly at phospholipid synthesis.

Alpha-glycerophosphocholine is a deacylated metabolite of phosphatidylcholine and one of the intermediates formed when lecithin is digested. Taking both supplies choline through overlapping routes. Total choline intake is therefore additive and worth counting once, not twice.

Citicoline is the activated intermediate of the Kennedy pathway that builds phosphatidylcholine, so it and lecithin sit on the same synthetic line at different points. Combining them raises total choline delivery. The overlap means the contributions should be summed rather than treated as separate nutrients.

Bile salts and dietary phospholipid are the two natural components of mixed micelles in the small intestine. Supplying both supports the emulsification step of fat handling from either side. This is digestive physiology rather than a tested product combination.

Pancreatic lipase works at the oil-water interface, so its rate depends on how finely the fat is emulsified. Lecithin increases that interfacial area. Phospholipase A2 in turn acts on the lecithin itself, converting it to lysolecithin, which is a stronger emulsifier again.

Multi-enzyme blends are limited by substrate presentation as much as by enzyme quantity. An emulsifier improves the dispersion of the fat fraction of a meal before lipase acts. The pairing is a formulation logic drawn from digestive physiology.

Quercetin aglycone is poorly water soluble and is commonly formulated as a phospholipid complex, where it associates with the polar head of phosphatidylcholine. That complex disperses far better in gastrointestinal fluid than the raw powder. The endpoint measured in these studies is plasma concentration, a delivery marker.

Resveratrol has low aqueous solubility and heavy first-pass conjugation, and phospholipid complexes are one of the formulation answers used against the first problem. Lecithin supplies the phospholipid for that complex. Improved dispersion does not by itself address the conjugation step.

Boswellic acids are lipophilic triterpenes with limited oral uptake, and lecithin-based phytosome formats were developed to address that. The phospholipid forms a complex with the acid groups. Reported gains are in measured plasma levels of the boswellic acids.

Silybin is the classic phospholipid-complex botanical, with lecithin-bound preparations developed specifically because free silymarin is poorly absorbed. The complex forms between phosphatidylcholine and the flavonolignan. Studies here report plasma silybin, an absorption marker.